Phase Forward Inks Multi-Year, Multi-Million Dollar Contract Commitment with Everest Clinical Research Services Inc.

WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year, multi-million dollar agreement with Everest Clinical Research Services Inc. (Everest), a contract research organization (CRO). This agreement extends a contract signed in 2007 and calls for Everest to leverage both Phase Forward’s InForm™ Integrated Trial Management (ITM) and its hosted Central Designer™ module Electronic Data Capture (EDC) solution.